Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
---|---|---|---|---|---|---|
URGN | UroGen Pharma Ltd. | Director | $26.7M | Oct 21, 2022 | ||
ELOX | Eloxx Pharmaceuticals, Inc. | Director | Jun 15, 2022 | |||
KROS | Keros Therapeutics, Inc. | Director, 10%+ Owner | May 30, 2024 |
Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
---|